Alnylam Pharmaceuticals partners with Sharp on packaging RNA interference therapeutics for Europe
Alnylam Pharmaceuticals Inc., the leading RNA interference (RNAi) therapeutics company, and Sharp, part of UDG Healthcare, announced an agreement for the packaging of Alnylam’s...
Cergentis expands product portfolio
Cergentis, a genomics company that develops and commercializes kits and services based on its proprietary Targeted Locus Amplification (TLA) technology, announced the expansion of...
PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products
PharmaSources.com, the vertical B2B portal for the pharmaceutical industry, announces the launch of the virtual session CPhI China Top API Exporters & Products on...
PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August to...
Takeda and Evotec Enter into Gene Therapy Research Alliance
Takeda Pharmaceutical and a subsidiary of Germany-based Evotec SE forged a long-term research collaboration that will support the Japanese company’s growing number of research...
Debiopharm Announces Exclusive In-Licensing of 3BP’s Targeted CAIX Radiotherapy
Debiopharm has entered into a worldwide, exclusive license & research agreement with 3B Pharmaceuticals (3BP), a German biotechnology firm, to further the development of...
CPhI announces new pharma events calendar for 2020
The CPhI Pharma portfolio confirms new exhibition dates for CPhI Japan, CPhI South East Asia and CPhI North America. Following a detailed review of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...